These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7083458)

  • 1. VM26 therapy in children with drug-refractory lymphocytic leukemia.
    Rivera G; Dahl GV; Murphy SB; Bowman WP; Aur RJ; Avery TL; Simone JV
    Cancer Chemother Pharmacol; 1982; 7(2-3):169-72. PubMed ID: 7083458
    [No Abstract]   [Full Text] [Related]  

  • 2. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
    Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
    Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
    [No Abstract]   [Full Text] [Related]  

  • 3. VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia.
    Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Risso M; Vimercati R; Cerri R; Rossi E
    Haematologica; 1984; 69(6):747-51. PubMed ID: 6441752
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
    Rafecas FJ; Sanz MA
    Sangre (Barc); 1984; 29(6):1052-3. PubMed ID: 6598235
    [No Abstract]   [Full Text] [Related]  

  • 5. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
    Rivera GK
    J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
    [No Abstract]   [Full Text] [Related]  

  • 6. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
    Rivera G; Bowman WP; Murphy SB; Dahl GV; Aur RJ; Kalwinsky DK; Wood A; Stagner S; Avery TL
    Med Pediatr Oncol; 1982; 10(5):439-46. PubMed ID: 6958957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teniposide is not effective in chronic lymphocytic leukemia.
    Zagonel V; Tirelli U; Veronesi A; Galligioni E; Tumolo S; Roncadin M; Carbone A; Grigoletto E
    Blut; 1986 Jan; 52(1):59-61. PubMed ID: 3632912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teniposide (VM26) disposition in children with leukemia.
    Sinkule JA; Stewart CF; Crom WR; Melton ET; Dahl GV; Evans WE
    Cancer Res; 1984 Mar; 44(3):1235-7. PubMed ID: 6581866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
    Rosenstock JG; Donaldson MH
    Cancer Treat Rep; 1976 Mar; 60(3):265-7. PubMed ID: 1063066
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
    Rivera G; Aur RJ; Dahl GV; Pratt CB; Wood A; Avery TL
    Cancer; 1980 Mar; 45(6):1284-8. PubMed ID: 7357520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
    Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
    [No Abstract]   [Full Text] [Related]  

  • 12. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
    Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
    J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The present of situation in treatment and prognosis of childhood acute lymphocytic leukemia with an outlook for the future.
    Simone JV
    Haematologica; 1982 Jun; 67(3):329-34. PubMed ID: 6814989
    [No Abstract]   [Full Text] [Related]  

  • 14. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 15. VM26 in malignant hematological diseases. A phase II study.
    Tirelli U; Carbone A; Franchin G; Galligioni E; Veronesi A; Trovo MG; Volpe R; Tumolo S; Grigoletto E
    Cancer Chemother Pharmacol; 1982; 7(2-3):173-4. PubMed ID: 6952964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
    Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
    Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine.
    Dahl GV; Rivera G; Pui CH; Mirro J; Ochs J; Kalwinsky DK; Abromowitch M; Look AT; Murphy SB
    Blood; 1985 Nov; 66(5):1110-4. PubMed ID: 3840395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.
    Bodey GP; Coltman CA; Freireich EJ; Bonnet JD; Gehan EA; Haut AB; Hewlett JS; McCredit KB; Saiki JH; Wilson HE
    Arch Intern Med; 1974 Feb; 133(2):260-6. PubMed ID: 4521468
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy in chronic lymphocytic leukaemia.
    Wiltshaw E
    Clin Haematol; 1977 Feb; 6(1):223-35. PubMed ID: 334412
    [No Abstract]   [Full Text] [Related]  

  • 20. [General remarks on the treatment of acute leukemias].
    Bernard J
    Minerva Med; 1975 Jul; 66(52):2625-8. PubMed ID: 1057057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.